Common therapeutic strategies in the management of sexual dysfunction and cardiovascular disease

Current Drug Targets - Cardiovascular and Haematological Disorders

Volumn 5, Issue 2, 2005, Pages 185-195

  Hale, T M ^a,b   Hannan, J L ^a   Heaton, J P W ^a   Adams, M A ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Cardiovascular disease; Female; Hypertension; Male; Pharmacotherapy; Sexual dysfunction

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; APOMORPHINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; PAPAVERINE; PHENTOLAMINE; PHOSPHODIESTERASE V INHIBITOR; PROSTAGLANDIN E1; RENIN INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SILDENAFIL; TADALAFIL; TESTOSTERONE; VARDENAFIL;

ALCOHOL WITHDRAWAL; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; DISEASE COURSE; DRUG APPROVAL; DRUG MECHANISM; DRUG TARGETING; DYSPAREUNIA; ERECTILE DYSFUNCTION; EXERCISE; FEMALE; HUMAN; HYPERTENSION; LIFESTYLE; MALE; NONHUMAN; ORGASM DISORDER; PATIENT COUNSELING; PENIS ARTERY; PENIS ERECTION; PREVALENCE; RAT; REVIEW; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; VAGINAL DRYNESS; VASCULAR ENDOTHELIUM; VASODILATATION; WEIGHT REDUCTION;

CARDIOVASCULAR DISEASES; HUMANS; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL;

EID: 18444377883     PISSN: 15680061     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568006043586143     Document Type: Review

References (131)

1. Laumann, E.O., Paik, A., Rosen, R.C. Sexual dysfunction in the United States: prevalence and predictors. JAMA, 1999, 281, 537-514.
2. Morley, J.E., Kaiser, F.E. Sexual function with advancing age. Med. Clin. North. Am., 1989, 73, 1483-1495.
3. Duncan, L.E., Lewis, C., Smith, C.E., Jenkins, P., Nichols, M., Pearson, T.A. Sex, drugs, and hypertension: a methodological approach for studying a sensitive subject. Int. J. Impot. Res., 2001, 13, 31-40.
4. Feldman, H.A., Johannes, C.B., Derby, C.A., Kleinman, K.P., Mohr, B.A., Araujo, A.B., McKinlay, J.B. Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study. Prev. Med., 2000, 30, 328-338.
5. Feldman, H.A., Goldstein, I., Hatzichristou, D.G., Krane, R.J., McKinlay, J.B. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J. Urol., 1994, 151, 54-61.
6. DeBusk, R., Drory, Y., Goldstein, I., Jackson, G., Kaul, S., Kimmel, S.E., Kostis, J.B., Kloner, R.A., Lakin, M., Meston, C.M., Mittleman, M., Muller, J.E., Padma, N., Rosen, R.C., Stein, R.A., Zusman, R. Management of sexual dysfunction in patients with cardiovascular disease: recommendations of the Princeton Consensus Panel. Am. J. Cardiol., 2000, 86, 62F-68F.
7. Prather, R.C. Sexual dysfunction in the diabetes female: a review. Arch. Sex Behav., 1988, 17, 277-284.
8. Wei, M., Macera, C.A., Davis, D.R., Hornung, C.A., Nankin, H.R., Blair, S.N. Total cholesterol and high density lipoprotein cholesterol as important predictors of erectile dysfunction. Am. J. Epidemiol., 1994, 140, 930-937.
9. Kloner, R.A., Speakman, M. Erectile dysfunction and atherosclerosis. Curr. Atheroscler. Rep., 2002, 4, 397-401.
10. Greenstein, A., Chen, J., Miller, H., Matzkin, H., Villa, Y., Braf, Z. Does severity of ischemic coronary disease correlate with erectile function? Int. J. Impot. Res., 1997, 9, 123-126.
11. Erol, B., Tefekli, A., Ozbey, I., Salman, F., Dincag, N., Kadioglu, A., Tellaloglu, S. Sexual dysfunction in type II diabetic females: a comparative study. J. Sex Marital Ther., 2002, 28 Suppl. 1, 55-62.
12. Hultgren, R., Sjogren, B., Soderberg, M., Takolander, R., Wahlberg, E., Wahlberg, M., Olofsson, P. Sexual function in women suffering from aortoiliac occlusive disease. Eur. J. Vasc. Endovasc. Surg. 1999, 17, 306-312.
13. Duncan, L.E., Lewis, C., Jenkins, P., Pearson, T.A. Does hypertension and its pharmacotherapy affect the quality of sexual function in women? Am. J. Hypertens., 2000, 13, 640-647.
14. Newman, H.F., Northup, J.D. Mechanism of human penile erection: an overview. Urology, 1981, 17, 399-408.
15. Weiss, H.D. The physiology of human penile erection. Ann. Intern. Med., 1972, 76, 793-799.
16. Berman, J.R., Adhikari, S.P., Goldstein, I. Anatomy and physiology of female sexual function and dysfunction: classification, evaluation and treatment options. Eur. Urol., 2000, 38, 20-29.
17. Munarriz, R., Kim, N.N., Goldstein, I., Traish, A.M. Biology of female sexual function. Urol. Clin. North. Am., 2002, 29, 685-693.
18. Andersson, K.E., Wagner, G. Physiology of penile erection. Physiol. Rev., 1995, 75, 191-236.
19. Anderson, K.E. Pharmacology of lower urinary tract smooth muscles and penile erectile tissues. Pharmacol. Rev., 1993, 45, 253-308.
20. Ignarro, L.J., Bush, P.A., Buga, G.M., Wood, K.S., Fukuto, J.M., Rajfer, J. Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle. Biochem. Biophys. Res. Commun., 1990, 170, 843-850.
21. Hedlund, H., Andersson, K.E. Contraction and relaxation induced by some prostanoids in isolated human penile erectile tissue and cavernous artery. J. Urol., 1985, 134, 1245-1250.
22. Stief, C.G., Benard, F., Bosch, R.J., Aboseif, S.R., Lue, T.F., Tanagho, E.A. A possible role for calcitonin-gene-related peptide in the regulation of the smooth muscle tone of the bladder and penis. J. Urol., 1990, 143, 392-397.
23. Andersson, P.O., Bloom, S.R., Mellander, S. Haemodynamics of pelvic nerve induced penile erection in the dog: possible mediation by vasoactive intestinal polypeptide. J. Physiol., 1984, 350, 209-224.
24. Berman, J.R., Bassuk, J. Physiology and pathophysiology of female sexual function and dysfunction. World J. Urol., 2002, 20, 111-118.
25. Goldstein, I., Berman, J.R. Vasculogenic female sexual dysfunction: vaginal engorgement and clitoral erectile insufficiency syndromes. Int J. Impot. Res., 1998, 10 Suppl. 2, S84-S90.
26. Levin, R.J. VIP, vagina, clitoral and periurethral glans--an update on human female genital arousal. Exp. Clin. Endocrinol., 1991, 98, 61-69.
27. Giuliano, F., Rampin, O. Central neural regulation of penile erection. Neurosci. Biobehav. Rev., 2000, 24, 517-533.
28. Ottesen, B., Pedersen, B., Nielsen, J., Dalgaard, D., Wagner, G., Fahrenkrug, J. Vasoactive intestinal polypeptide (VIP) provokes vaginal lubrication in normal women. Peptides, 8, 797-800.
29. Aboseif, S.R., Breza, J., Orvis, B.R., Lue, T.F., Tanagho, E.A. Erectile response to acute and chronic occlusion of the internal pudendal and penile arteries. J. Urol., 1989, 141, 398-402.
30. Jensen, J., Lendorf, A., Stimpel, H., Frost, J., Ibsen, H., Rosenkilde, P. The prevalence and etiology of impotence in 101 male hypertensive outpatients. Am. J. Hypertens., 1999, 12, 271-275.
31. Adams, M.A., Banting, J.D., Maurice, D.H., Morales, A., Heaton, J.P. Vascular control mechanisms in penile erection: phylogeny and the inevitability of multiple and overlapping systems. Int. J. Impot. Res., 1979, 9, 85-91.
32. Zweifach, B.W., Lipowski, H.H. Microcirculation, part 1. 1984, 251-307.
33. Manabe, K., Heaton, J.P., Morales, A., Kumon, H., Adams, M.A. Pre-penile arteries are dominant in the regulation of penile vascular resistance in the rat. Int. J. Impot. Res., 2000, 12, 183-189.
34. Cuellar de Leon, A.J., Ruiz Garcia, V., Campos Gonzalez, J.C., Perez Hoyos, S., Brotons Multo, F. [Prevalence erectile dysfunction in patients with hypertension]. Med. Clin. (Barc.), 2002, 119, 521-526.
35. Morillo, L.E., Diaz, J., Estevez, E., Costa, A., Mendez, H., Davila, H., Medero, N., Rodriguez, N., Chaves, M., Vinueza, R., Ortiz, J.A., Glasser, D.B. Prevalence of erectile dysfunction in Colombia, Ecuador, and Venezuela: a population-based study (DENSA). Int. J. Impot. Res., 2002, 14 Suppl. 2, S10-S18.
36. Moreira, E.D., Bestane, W.J., Bartolo, E.B., Fittipaldi, J.A. Prevalence and determinants of erectile dysfunction in Santos, southeastern Brazil. Sao Paulo Med. J., 2002, 120, 49-54.
37. Akkus, E., Kadioglu, A., Esen, A., Doran, S., Ergen, A., Anafarta, K., Hattat, H. Prevalence and correlates of erectile dysfunction in Turkey: a population-based study. Eur. Urol., 2002, 41, 298-304.
38. Vaaler, S., Lovkvist, H., Svendsen, K.O., Furuseth, K. [Erectile dysfunction among Norwegian men over 40 years of age]. Tidsskr. Nor. Laegeforen., 2001, 121, 28-32.
39. Rosen, R.C. Prevalence and risk factors of sexual dysfunction in men and women. Curr. Psychiatry Rep., 2000, 2, 189-195.
40. McVary, K.T., Carrier, S., Wessells, H. Smoking and erectile dysfunction: evidence based analysis. J. Urol., 2001, 166, 1624-1632.
41. Andersson, K.E. Pharmacology of penile erection. Pharmacol. Rev., 2001, 53, 417-450.
42. De Angelis, L., Marfella, M.A., Siniscalchi, M., Marino, L., Nappo, F., Giugliano, F., De Lucia, D., Giugliano, D. Erectile and endothelial dysfunction in Type II diabetes: a possible link. Diabetologia, 2001, 44, 1155-1160.
43. Schiavi, R.C., Stimmel, B.B., Mandeli, J., Rayfield, E.J. Diabetes mellitus and male sexual function: a controlled study. Diabetologia, 1993, 36, 745-751.
44. Lue, T.F. Erectile dysfunction. N. Engl. J. Med., 2000, 342, 1802-1813.
45. Quek, K.F., Razack, A.H., Chua, C.B., Low, W.Y., Loh, C.S. Sexual function outcomes following treatment for lower urinary tract symptoms. A one-year study. Med. J. Malaysia, 2003, 58, 735-742.
46. Vale, J. Benign prostatic hyperplasia and erectile dysfunction--is there a link? Curr. Med. Res. Opin., 2000, 16 Suppl. 1, s63-s67.
47. Seidman, S.N. Testosterone deficiency and mood in aging men: pathogenic and therapeutic interactions. World J. Biol. Psychiatry., 2003, 4, 14-20.
48. Heaton, J.P., Varrin, S.J. Effects of castration and exogenous testosterone supplementation in an animal model of penile erection. J. Urol., 1994, 151, 797-800.
49. Garban, H., Marquez, D., Cai, L., Rajfer, J., Gonzalez, C. Restoration of normal adult penile erectile response in aged rats by long-term treatment with androgens. Biol. Reprod., 1995, 53, 1365-1372.
50. Wespes, E., Schulman, C.C. Male andropause: myth, reality, and treatment. Int. J. Impot. Res., 2002, 14 Suppl. 1, S93-S98.
51. Carrier, S. Nagaraju, P., Morgan, D.M., Baba, K., Nunes, L., Lue, T.F. Age decreases nitric oxide synthase-containing nerve fibers in the rat penis. J. Urol., 1997, 157, 1088-1092.
52. Dahiya, R., Lin, A., Bakircioglu, M.E., Huang, S.T., Lue, T.F. mRNA and protein expression of nitric oxide synthase and adrenoceptor alpha 1 in young and old rat penile tissues. Br. J. Urol., 1997, 80, 300-306.
53. Ruzbarsky, V., Michal, V. Morphologic changes in the arterial bed of the penis with aging. Relationship to the pathogenesis of impotence. Invest. Urol., 1977, 15, 194-199.
54. Burchardt, M., Burchardt, T., Baer, L., Kiss, A.J., Pawar, R.V., Shabsigh, A., de la Taille, A., Hayek, O.R., Shabsigh, R. Hypertension is associated with severe erectile dysfunction. J. Urol., 2000, 164, 1188-1191.
55. Srilatha, B., Adaikan, P.G., Arulkumaran, S., Ng, S.C. Sexual dysfunction related to antihypertensive agents: results from the animal model. Int. J. Impot. Res., 1999, 11, 107-113.
56. Fogari, R., Preti, P., Derosa, G., Marasi, G., Zoppi, A., Rinaldi, A., Mugellini, A. Effect of antihypertensive treatment with valsartan or atenolol oil sexual activity and plasma testosterone in hypertensive men. Eur. J. Clin. Pharmacol., 2002, 58, 177-180.
57. Hanon, O., Mounier-Vehier, C., Fauvel, J.P., Marquand, A., Jaboureck, O., Justin, E.P., Kearney-Schwartz, A., Girerd, X. [Sexual dysfunction in treated hypertensive patients. Results of a national survey]. Arch. Mal. Coeur. Vaiss., 2002, 95, 673-677.
58. Okabe, H., Hale, T.M., Kumon, H., Heaton, J.P., Adams, M.A. The penis is not protected-in hypertension there are vascular changes in the penis which are similar to those in other vascular beds. Int. J. Impot. Res., 1999, 11, 133-140.
59. Toblli, J.E., Stella, I., Inserra, F., Ferder, L., Zeller, F., Mazza, O.N. Morphological changes in cavernous tissue in spontaneously hypertensive rats. Am. J. Hypertens., 2000, 13, 686-692.
60. Behr-Roussel, D., Chamiot-Clerc, P., Bernabe, J., Mevel, K., Alexandre, L., Safar, M.E., Giuliano, F. Erectile dysfunction in spontaneously hypertensive rats: pathophysiological mechanisms. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2003, 284, R682-R688.
61. Azadzoi, K.M., Goldstein, I. Erectile dysfunction due to atherosclerotic vascular disease: the development of an animal model. J. Urol., 1992, 147, 1675-1681.
62. Azadzoi, K.M., Goldstein, I., Siroky, M.B., Traish, A.M., Krane, R.J., Saenz de Tajeda, I. Mechanisms of ischemia-induced cavernosal smooth muscle relaxation impairment in a rabbit model of vasculogenic erectile dysfunction. J. Urol., 1998, 160, 2216-2222.
63. Azadzoi, K.M., Siroky, M.B., Goldstein, I. Study of etiologic relationship of arterial atherosclerosis to corporal veno-occlusive dysfunction in the rabbit. J. Urol., 1996, 155, 1795-1800.
64. Behr-Roussel, D., Bernabe, J., Compagnie, S., Rupin, A., Verbeuren, T.J., Alexandre, L., Giuliano, F. Distinct mechanisms implicated in atherosclerosis-induced erectile dysfunction in rabbits. Athero-sclerosis, 2002, 162, 355-362.
65. Berman, J.R., Berman, L., Goldstein, I. Female sexual dysfunction: incidence, pathophysiology, evaluation, and treatment options. Urology, 1999, 54, 385-391.
66. Heiman, J.R. Psychologic treatments for female sexual dysfunction: are they effective and do we need them? Arch. Sex Behav., 2002, 31, 445-450.
67. Leiblum, S.R. Definition and classification of female sexual disorders. Int. J. Impot. Res., 1998, 10 Suppl. 2, S104-S106.
68. Basson, R., Berman, J., Burnett, A., Derogatis, L., Ferguson, D., Fourcroy, J., Goldstein, I., Graziottin, A., Heiman, J., Laan, E., Leiblum, S., Padma, N., Rosen, R., Segraves, K., Segraves, R.T., Shabsigh, R., Sipski, M., Wagner, G., Whipple, B. Report of the international consensus development conference on female sexual dysfunction: definitions and classifications. J. Urol., 2000, 163, 888-893.
69. Park, K. Goldstein, I., Andry, C., Siroky, M.B., Krane, R.J., Azadzoi, K.M. Vasculogenic female sexual dysfunction: the hemodynamic basis for vaginal engorgement insufficiency and clitoral erectile insufficiency. Int. J. Impot. Res., 1997, 9, 27-37.
70. Zemel, P. Sexual dysfunction in the diabetic patient with hypertension. Am. J. Cardiol., 1988, 61, 27H-33H.
71. Burchardt, M., Burchardt, T., Anastasiadis, A.G., Kiss, A.J., Baer, L., Pawar, R.V., de la Taille, A., Shabsigh, A., Ghafar, M.A., Shabsigh, R. Sexual dysfunction is common and overlooked in female patients with hypertension. J. Sex Marital. Ther., 2000, 28, 17-26.
72. Tarcan, T., Park, K., Goldstein, I., Maio, G., Fassina, A., Krane, R.J., Azadzoi, K.M. Histomorphometric analysis of age-related structural changes in human clitoral cavernosal tissue. J. Urol., 1999, 161, 940-944.
73. Lewis, C., Duncan, L.E., Ballance, D.I., Pearson, T.A. Is sexual dysfunction in hypertensive women uncommon or understudied? Am. J. Hypertens., 1998, 11, 733-735.
74. Anastos, K., Charney, P., Charon, R.A., Cohen, E., Jones, C.Y., Marte, C., Swiderski, D.M., Wheat, M.E., Williams, S. Hypertension in women: what is really known? The Women's Caucus, Working Group on Women's Health of the Society of General Internal Medicine. Ann. Intern. Med., 1991, 115, 287-293.
75. Park, K., Tarcan, T., Goldstein, I., Siroky, M.B., Krane, R.J., Azadzoi, K.M. Atherosclerosis-induced chronic arterial insufficiency causes clitoral cavernosal fibrosis in the rabbit. Int. J. Impot. Res., 2000, 12, 111-116.
76. Bechara, A.J., Cao, G., Casabe, A.R., Romano, S.V., Toblli, J.E. Morphological modifications in clitoris and vagina in spontaneously hypertensive rats. Int. J. Impot. Res., 2003, 15, 166-172.
77. Giammusso, B., Motta, M. [Retrospective study on the incidence and cause of drop-out during intracavernous pharmaco-prosthesis therapy]. Arch. Ital. Urol. Androl., 2002, 74, 27-31.
78. Lue, T.F., Lee, K.L. Pharmacotherapy for erectile dysfunction. Chin. Med. J. (Engl.), 2000, 113, 291-298.
79. Purvis, K., Egdetveit, I., Christiansen, E. Intracavernosal therapy for erectile failure--impact of treatment and reasons for drop-out and dissatisfaction. Int. J. Impot. Res., 1999, 11, 287-299.
80. Sundaram, C.P., Thomas, W., Pryor, L.E., Sidi, A.A., Billups, K., Pryor, J.L. Long-term follow-up of patients receiving injection therapy for erectile dysfunction. Urology, 1997, 49, 932-935.
81. Simonsen, U. Interactions between drugs for erectile dysfunction and drugs for cardiovascular disease. Int. J. Impot. Res., 2002, 14, 178-188.
82. Brien, S.E., Wilson, E., Heaton, J.P., Adams, M.A. The conditioned response erection (CRE)--a new approach to modelling erectile responses in the rat. Int. J. Impot. Res., 2000, 12, 91-96.
83. Schiffrin, E.L. Small artery remodeling in hypertension: can it be corrected? Am. J. Med, Sci., 2001, 322, 7-11.
84. Schiffrin, E.L. Vascular changes in hypertension in response to drug treatment: Effects of angiotensin receptor blockers. Can. J. Cardiol., 2002, 18 Suppl. A, 15A-18A.
85. Kaplan, S.A., Reis, R.B., Kohn, I.J., Ikeguchi, E.F., Laor, E., Te, A.E., Martins, A.C. Safety and efficacy of sildenafil in postmenopausal women with sexual dysfunction. Urology, 1999, 53, 481-486.
86. Shen, W.W., Urosevich, Z., Clayton, D.O. Sildenafil in the treatment of female sexual dysfunction induced by selective serotonin reuptake inhibitors. J. Reprod. Med,, 1999, 44, 535-542.
87. Sipski, M.L., Rosen, R.C., Alexander, C.J., Hamer, R.M. Sildenafil effects on sexual and cardiovascular responses in women with spinal cord injury. Urology, 2000, 55, 812-815.
88. Rissman, E.F., Clendenon, A.L., Krohmer, R.W. Role of androgens in the regulation of sexual behavior in the female musk shrew. Neuroendocrinology, 1990, 51, 468-473.
89. Freedman, M.A. Quality of life and menopause: the role of estrogen. J. Womens Health (Larchmt.), 2002, 11, 703-718.
90. Lobo, R.A., Rosen, R.C., Yang, H.M., Block, B., Van Der Hoop, R.G. Comparative effects of oral esterified estrogens with and without methyltestosterone on endocrine profiles and dimensions of sexual function in postmenopausal women with hypoactive sexual desire. Fertil. Steril., 2003, 79, 1341-1352.
91. Basson, R. Androgen replacement for women. Can. Fam. Physician., 1999, 45, 2100-2107.
92. Beharry, R.K., Hale, T.M., Wilson, E.A., Heaton, J.P., Adams, M.A. Evidence for centrally initiated genital vasocongestive engorgement in the female rat: findings from a new model of female sexual arousal response. Int. J. Impot. Res., 2003, 15, 122-128.
93. Hamburger, B., Rigter, H. Apomorphine: facilitation of sexual behaviour in female rats. Eur. J. Pharmacol., 32, 357-360.
94. Rosen, R.C., Phillips, N.A., Gendrano, N.C.I., Ferguson, D.M. Oral phentolamine and female sexual arousal disorder: a pilot study. J. Sex Marital. Ther., 1999, 25, 137-144.
95. Islam, A., Mitchel, J., Rosen, R., Phillips, N., Ayers, C., Ferguson, D., Yeager, J. Topical alprostadil in the treatment of Female Sexual Arousal Disorder: a pilot study. J. Sex Marital. Ther., 2001, 27, 531-540.
96. Barksdale, J.D., Gardner, S.F. The impact of first-line antihypertensive drugs on erectile dysfunction. [Review] [52 refs]. Pharmacotherapy, 1999, 19, 573-581.
97. Rosen, R.C., Kostis, J.B., Jekelis, A., Taska, L.S. Sexual sequelae of antihypertensive drugs: treatment effects on self- report and physiological measures in middle-aged male hypertensives. Arch. Sex Behav., 1994, 23, 135-152.
98. Croog, S.H., Levine, S., Sudilovsky, A., Baume, R.M., Clive, J. Sexual symptoms in hypertensive patients. A clinical trial of antihypertensive medications. Arch. Intern. Med., 1988, 148, 788-794.
99. Drugs that cause sexual dysfunction: an update. Med. Lett. Drugs Ther, 1992, 34, 73-78.
100. Fogari, R., Zoppi, A. Effects of antihypertensive therapy on sexual activity in hypertensive men. Curr. Hypertens. Rep., 2002, 4, 202-210.
101. Suzuki, H., Tominaga, T., Kumagai, H., Saruta, T. Effects of first-line antihypertensive agents on sexual function and sex hormones. J. Hypertens. Suppl., 1988, 6, S649-S651.
102. Rosenthal, T., Algom, M., Chagnac, A., Grossman, E., Kisch, E., Leiba, M., Paran, E. Captopril as a replacement therapy in hypertension improving quality of life--a multicentre study. Postgrad. Med. J., 1986, 62 Suppl. 1, 114-115.
103. Fogari, R., Zoppi, A., Poletti, L., Marasi, G., Mugellini, A., Corradi, L. Sexual activity in hypertensive men treated with valsartan or carvedilol: a crossover study. Am. J. Hypertens., 2001, 14, 27-31.
104. Hodge, R.H., Harward, M.P., West, M.S., Krongaard, D., Kowal, N. Sexual function of women taking antihypertensive agents: a comparative study. J. Gen. Intern. Med., 6, 290-294.
105. Duncan, L., Bateman, D.N. Sexual function in women. Do antihypertensive drugs have an impact? Drug Saf., 1993, 8, 225-234.
106. Llisterri, J.L., Lozano Vidal, J.V., Aznar, V.J., Argaya, R.M., Pol, B.C., Sanchez Zamorano, M.A., Ferrario, C.M. Sexual dysfunction in hypertensive patients treated with losartan. Am. J. Med. Sci., 2001, 321, 336-341.
107. Chan, P., Liu, J.C., Tong, Y.C., Chen, Y.J., Wang, C.C., Tomlinson, B., Cheng, J.T. Effects of losartan on the sexual behavior of male rats. Pharmacology, 1999, 58, 132-139.
108. Hale, T.M., Okabe, H., Bushfield, T.L., Heaton, J.P., Adams, M.A. Recovery of erectile function after brief aggressive antihypertensive therapy. J. Urol., 2002, 168, 348-354.
109. Dorrance, A.M., Lewis, R.W., Mills, T.M. Captopril treatment reverses erectile dysfunction in male stroke prone spontaneously hypertensive rats. Int. J. Impot. Res., 2002, 14, 494-497.
110. Hale, T.M., Okabe, H., Heaton, J.P., Adams, M.A. Antihypertensive drugs induce structural remodeling of the penile vasculature. J. Urol., 2001, 166, 739-745.
111. Poredos, P. Endothelial dysfunction and cardiovascular disease. Pathophysiol. Haemost. Thromb., 32, 274-277.
112. Cai, H., Harrison, D.G. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circulation Research, 2000, 87, 840-844.
113. Maas, R., Schwedhelm, E,, Albsmeier, J., Boger, R.H. The pathophysiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular function. Vasc. Med., 2002, 7, 213-225.
114. Solomon, H., Man, J.W., Jackson, G. Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator. Heart, 2003, 89, 251-253.
115. Walia, M., Kwan, C.Y., Grover, A.K. Effects of free radicals on coronary artery. Med. Princ. Pract., 2003, 12, 1-9.
116. Matz, R., Andriantsitohaina, R. Age-related endothelial dysfunction: potential implications for pharmacotherapy. Drugs Aging, 2003, 20, 527-550.
117. Paradisi, G., Steinberg, H.O., Hempfling, A., Cronin, J., Hook, G., Shepard, M.K., Baron, A.D. Polycystic ovary syndrome is associated with endothelial dysfunction. Circulation, 2001, 103, 1410-1415.
118. Herman, S.M., Robinson, J.T., McCredie, R.J., Adams, M.R., Boyer, M.J., Celermajer, D.S. Androgen deprivation is associated with enhanced endothelium-dependent dilatation in adult men. Arterioscler. Thromb. Vasc. Biol., 1997, 17, 2004-2009.
119. Loscalzo, J. Oxidative stress in endothelial cell dysfunction and thrombosis. Pathophysiol. Haemost. Thromb., 32, 359-360.
120. Annuk, M., Zilmer, M., Fellstrom, B. Endothelium-dependent vasodilation and oxidative stress in chronic renal failure: impact on cardiovascular disease. Kidney Int. Suppl., 2003, S50-S53.
121. Halliwell, B. The role of oxygen radicals in human disease, with particular reference to the vascular system. Haemostasis, 1993, 23 Suppl. 1, 118-126.
122. Romero, F.J., Bosch, M., Romero, M.J., Jareno, E.J., Romero, B., Marin, N., Roma, J. Lipid peroxidation products and antioxidants in human disease. Environ Health Perspect., 1998, 106 Suppl. 5, 1229-1234.
123. Wilcox, C.S. Reactive oxygen species: roles in blood pressure and kidney function. Curr. Hypertens. Rep., 2002, 4, 160-166.
124. Dzau, V.J. Theodore Cooper Lecture: Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis. Hypertension, 2001, 37, 1047-1052.
125. Hatta, T., Nakata, T., Harada, S., Kiyama, M., Moriguchi, J., Morimoto, S., Rob, H., Sasaki, S., Takeda, K., Nakagawa, M. Lowering of blood pressure improves endothelial dysfunction by increase of nitric oxide production in hypertensive rats. Hypertens. Res., 2002, 25, 455-460.
126. On, Y.K., Kim, C.H., Oh, B.H., Lee, M.M., Park, Y.B. Effects of angiotensin converting enzyme inhibitor and calcium antagonist on endothelial function in patients with essential hypertension. Hypertens. Res., 2002, 25, 365-371.
127. Rizzoni, D., Porteri, E., Bettoni, G., Piccoli, A., Castellano, M., Muiesan, M.L., Pasini, G., Guelfi, D., Rosei, E.A. Effects of candesartan cilexetil and enalapril on structural alterations and endothelial function in small resistance arteries of spontaneously hypertensive rats. J. Cardiovasc. Pharmacol., 1998, 32, 798-806.
128. Ruilope, L.M., Schiffrin, E.L. Blood pressure control and benefits of antihypertensive therapy: does it make a difference which agents we use? Hypertension, 2001, 38, 537-542.
129. Dandona, P., Kumar, V., Aljada, A., Ghanim, H., Syed, T., Hofmayer, D., Mohanty, P., Tripathy, D., Garg, R. Angiotensin II receptor blocker valsartan suppresses reactive oxygen species generation in leukocytes, nuclear factor-kappa B, in mononuclear cells of normal subjects: evidence of an antiinflammatory action. Journal of Clinical Endocrinology Metabolism, 2003, 88, 4496-4501.
130. Adams, M.A., Bobik, A., Komer, P.I. Enalapril can prevent vascular amplifier development in spontaneously hypertensive rats. Hypertension, 1990, 16, 252-260.
131. Fogari, R., Zoppi, A., Corradi, L., Mugellini, A., Poletti, L., Lusardi, P. Sexual function in hypertensive males treated with lisinopril or atenolol: a cross-over study. Am. J. Hypertens., 1998, 11, 1244-1247.